Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/6797
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gul, H.I. | - |
dc.contributor.author | Cizmecioglu, M. | - |
dc.contributor.author | Zencir, Sevil. | - |
dc.contributor.author | Gul, M. | - |
dc.contributor.author | Canturk, P. | - |
dc.contributor.author | Atalay, M. | - |
dc.contributor.author | Topcu, Z. | - |
dc.date.accessioned | 2019-08-16T12:11:08Z | |
dc.date.available | 2019-08-16T12:11:08Z | |
dc.date.issued | 2009 | - |
dc.identifier.issn | 1475-6366 | - |
dc.identifier.uri | https://hdl.handle.net/11499/6797 | - |
dc.identifier.uri | https://doi.org/10.1080/14756360802399126 | - |
dc.description.abstract | Chalcones (1,3-diaryl-2-propen-1-ones) are ?, ß-unsaturated ketones with cytotoxic and anticancer properties. Several reports have shown that compounds with cytotoxic properties may also interfere with DNA topoisomerase functions. Five derivatives of 4'-hydroxychalcones were examined for cytotoxicity against transformed human T (Jurkat) cells as well as plasmid supercoil relaxation experiments using mammalian DNA topoisomerase I. The compounds were 3-phenyl-1-(4'-hydroxyphenyl)-2-propen-1-one (I), 3-(p-methylphenyl)-1-(4'-hydroxyphenyl)-2-propen-1-one (II), 3-(p-methoxyphenyl)-1-(4'-hydroxyphenyl)-2-propen-1-one (III), 3-(p-chlorophenyl)-1-(4'-hydroxyphenyl)-2-propen-1-one (IV), and 3-(2- thienyl)-1-(4'-hydroxyphenyl)-2-propen-1-one (V). The order of the cytotoxicity of the compounds was; IV > III > II > I > V. Compound IV, had the highest Hammett and log P values (0.23 and 4.21, respectively) and exerted both highest cytotoxicity and strongest DNA topoisomerase I inhibition. Compounds I and II gave moderate interference with the DNA topoisomerase I while III & V did not interfere with the enzyme. © 2009 Informa UK Ltd. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Journal of Enzyme Inhibition and Medicinal Chemistry | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | 40-hydroxychalcone | en_US |
dc.subject | Cytotoxicity | en_US |
dc.subject | DNA topoisomerase I | en_US |
dc.subject | Inhibition | en_US |
dc.subject | Jurkat cells | en_US |
dc.subject | MTT | en_US |
dc.subject | 3 (2 thienyl) 1 (4' hydroxyphenyl) 2 propen 1 one | en_US |
dc.subject | 3 (4 chlorophenyl) 1 (4' hydroxyphenyl) 2 propen 1 one | en_US |
dc.subject | 3 (4 methoxyphenyl) 1 (4' hydroxyphenyl) 2 propen 1 one | en_US |
dc.subject | 3 (4 methylphenyl) 1 (4' hydroxyphenyl) 2 propen 1 one | en_US |
dc.subject | 3 phenyl 1 (4' hydroxyphenyl) 2 propen 1 one | en_US |
dc.subject | 4' hydroxychalcone derivative | en_US |
dc.subject | antineoplastic agent | en_US |
dc.subject | chalcone derivative | en_US |
dc.subject | DNA topoisomerase | en_US |
dc.subject | unclassified drug | en_US |
dc.subject | 4-hydroxychalcone | en_US |
dc.subject | DNA topoisomerase inhibitor | en_US |
dc.subject | antineoplastic activity | en_US |
dc.subject | article | en_US |
dc.subject | cytotoxicity | en_US |
dc.subject | DNA supercoiling | en_US |
dc.subject | drug effect | en_US |
dc.subject | drug inhibition | en_US |
dc.subject | drug structure | en_US |
dc.subject | drug synthesis | en_US |
dc.subject | human | en_US |
dc.subject | human cell | en_US |
dc.subject | leukemia cell line | en_US |
dc.subject | mammal | en_US |
dc.subject | nonhuman | en_US |
dc.subject | plasmid | en_US |
dc.subject | priority journal | en_US |
dc.subject | animal | en_US |
dc.subject | Bovinae | en_US |
dc.subject | cell line | en_US |
dc.subject | chemistry | en_US |
dc.subject | IC50 | en_US |
dc.subject | jurkat cell line | en_US |
dc.subject | metabolism | en_US |
dc.subject | synthesis | en_US |
dc.subject | Animals | en_US |
dc.subject | Antineoplastic Agents | en_US |
dc.subject | Cattle | en_US |
dc.subject | Cell Line | en_US |
dc.subject | Chalcones | en_US |
dc.subject | DNA Topoisomerases, Type I | en_US |
dc.subject | Humans | en_US |
dc.subject | Inhibitory Concentration 50 | en_US |
dc.subject | Jurkat Cells | en_US |
dc.subject | Plasmids | en_US |
dc.subject | Mammalia | en_US |
dc.subject | Topoisomerase I Inhibitors | en_US |
dc.title | Cytotoxic activity of 4'-hydroxychalcone derivatives against Jurkat cells and their effects on mammalian DNA topoisomerase i | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 24 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | 804 | |
dc.identifier.startpage | 804 | en_US |
dc.identifier.endpage | 807 | en_US |
dc.identifier.doi | 10.1080/14756360802399126 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.pmid | 18830876 | en_US |
dc.identifier.scopus | 2-s2.0-70749136375 | en_US |
dc.identifier.wos | WOS:000266040700025 | en_US |
dc.identifier.scopusquality | Q2 | - |
dc.owner | Pamukkale University | - |
item.fulltext | No Fulltext | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.openairetype | Article | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
21
checked on Nov 23, 2024
WEB OF SCIENCETM
Citations
21
checked on Nov 22, 2024
Page view(s)
30
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.